Skip to main content
OpenTrials
Completed

NCT Number: NCT01455974

The Effects of Lowering Dialysate Sodium in Hypertensive Hemodialysis Patients

Unfavorably high sodium intakes remain prevalent around the world. A negative sodium gradient in hemodialysis treatment results in absolute sodium removal via diffusive transport of sodium from the blood to the dialysate, and it may be a potentially useful tool to improve sodium loading due to excess dietary sodium intake.

The purpose of this study is to determine whether a in small negative sodium gradient could improve blood pressure level, arterial stiffness and left ventricular hypertrophy in hypertensive hemodialysis patients, who had been achieving and maintaining their dry weight assessed by bioimpedance spectroscopy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Nephrology, Chao-Yang Hospital, Capital Medical University

Beijing, 100020, China

About this study

A number of studies have shown that lowering dialysate sodium concentration could improve blood pressure (BP) control, and the lower BPs are considered to be a result of an improvement in volume status via increasing sodium removal. However, sodium, apart from volume, may have an independent effect on BP regulation. It is speculated that a reduction in exchangeable sodium, even without a change in body water content, may improve BP control. Unfortunately, as of yet, no clinical studies have actually provided the evidence in this field.

In general population, dietary salt loading produces significant increase in aortic pulse wave velocity, which is reversed by lowering sodium intake. To the investigators knowledge, the effect of sodium on arterial stiffness has not been investigated in hemodialysis patients.

A regression of left ventricular hypertrophy (LVH) has been achieved through strict dietary sodium restriction in hemodialysis patients. Lack of effect on LVH was observed in low sodium dialysis which may be due to the shorter time interval.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • They had been on HD for more than 1 year.
  • They had had no clinical cardiovascular disease during 3 months preceding entry into the study, with left ventricular ejection fraction over 40%.
  • Their residual daily urine output was lower than 100 ml/day.
  • They had achieved their dry weight assessed by bioimpedance technique and clinical examination for at least 3 months.
  • A mean interdialytic ambulatory BP of >135/85 mmHg.
  • Averaging the last six available monthly pre-dialysis plasma sodium concentrations over the preceding 12 months >138mmol/l.

Exclusion criteria

  • They had known acute inflammatory event, malignant disease, and the serum albumine<30g/l.
  • They were diabetic and hypotension prone.

Treatment and study plan

Decreasing dialysate sodium from 138 mmol/L to 136 mmol/L

Other

After 1-month period of dialysis with standard dialysate sodium concentration 138mmol/L, patients were followed up over a 1-year period with dialysate sodium set at 136mmol/L, without changes in instructions to patients about dietary sodium.

Primary outcomes

  1. Changes in 44-hour ambulatory systolic and diastolic blood pressure

    Time frame: Baseline, 4 months, and 12 months

    The change is calculated as the 4 months minus baseline, and the 12 months minus baseline

Secondary outcomes

  1. Changes in aortic pulse wave velocity and left ventricular mass index

    Time frame: Baseline, 4 months, and 12 months

    The change is calculated as the 4 months minus baseline, and the 12 months minus baseline

Sponsors and collaborators

Lead sponsor

Capital Medical University

Other

Registry information

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Oct 20, 2011
Registry last updated
Oct 20, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.